We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Abaxis, Inc. (delisted) | NASDAQ:ABAX | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 83.00 | 82.85 | 83.01 | 0 | 01:00:00 |
From May 2019 to May 2024
UNION CITY, Calif., Oct. 18, 2016 /PRNewswire/ -- Abaxis, Inc. (NasdaqGS: ABAX), a global diagnostics company manufacturing point-of-care blood analysis instruments and consumables for the medical and veterinary markets worldwide, has scheduled a conference call to discuss its financial results for the second quarter fiscal year 2017, ended September 30, 2016. The call will be at 4:15 p.m. ET on Tuesday, October 25, 2016. The Company will report financial results for the second quarter fiscal year 2017 after the market closes on Tuesday, October 25, 2016.
Participants can dial (844) 855-9498 or (412) 317-5496 to access the conference call, or can listen via a live Internet web cast, which is available in the Investor Relations section of the Company's website at www.abaxis.com. A replay of the call is available by visiting www.abaxis.com for the next 30 days or by calling (877) 344-7529 or (412) 317-0088, confirmation code 10094876, through November 1, 2016.
About Abaxis
Abaxis, Inc. is a worldwide developer, manufacturer and marketer of portable blood analysis systems that are used in a broad range of medical specialties in human or veterinary patient care to provide clinicians with rapid blood constituent measurements. Our mission is to improve the efficiency of care delivery to and the quality of life of patients in the medical and veterinary markets. We provide leading edge technology and tools that support best medical practices, enabling physicians and veterinarians to respond to the health needs of their clients at the point of care while operating economical and profitable practices. For more information, visit http://www.abaxis.com
|
Contact: |
Clint Severson |
Lytham Partners, LLC |
|
Chief Executive Officer |
Joe Dorame, Joe Diaz & Robert Blum | |
|
Abaxis, Inc. |
602-889-9700 | |
|
510-675-6500 |
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/abaxis-to-report-second-quarter-fiscal-year-2017-financial-results-on-tuesday-october-25-2016-300346434.html
SOURCE Abaxis, Inc.
Copyright 2016 PR Newswire
1 Year Abaxis, Inc. (delisted) Chart |
1 Month Abaxis, Inc. (delisted) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
